Life Sciences

FDA to get more power?

Pharma Compliance Alert, August 6, 2008

The FDA will be able to levy fines, order drug recalls, and restrict drug-industry advertising if Senator Charles Grassley (R-IA) and Representative John Dingell (D-MI) have their way.

The two congressmen, both outspoken critics of the FDA, want to restructure the agency to reduce industry influence, according to a Wall Street Journal article.

The congressmen also want the agency to inspect generic-drug makers before approving new products and would allow the agency to impose significant fines.

Congress is unlikely to make major changes this year because it has only a brief session before the November elections, according to the article.

Comments

0 comments on “FDA to get more power?

 

Most Popular

Related Articles